Leukotriene B4 hydroxydehydrogenase
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | {{STRUCTURE_1zsv| PDB=1zsv | SIZE=400| SCENE=Leukotriene_B4_hydroxydehydrogenase/Cv/1 |right|CAPTION=Leukotriene B4 hydroxydehydrogenase tetramer complex with Cl- ions [[1zsv]]}} | ||
| - | [[Leukotriene B4 hydroxydehydrogenase]] (LB4H) is part of the arachidonic acid cycle and is | + | <StructureSection load='1v3v' size='350' side='right' caption='Human α-defensin 1 (PDB entry [[2pm4]])' scene=''> |
| + | == Function == | ||
| + | [[Leukotriene B4 hydroxydehydrogenase/15-oxo-prostaglandin 13-reductase]] (LB4H) is a bifunctional enzyme. It is part of the arachidonic acid cycle and is part of the metabolism of prostaglandins, leukotriene B4 and lipoxin. LB4H is san NADP-dependent enzyme. | ||
| + | == Relevance == | ||
| + | LB4H 1 restricts inflammation and confers resistance to tuberculosis infection<ref>PMID:23874453</ref>. | ||
| + | |||
| + | == Structural highlights == | ||
| + | LB4H active site is located at the hydrophobic pore on the dimer interface<ref>PMID:15007077</ref>. | ||
| + | </StructureSection> | ||
| + | == Structural highlights == | ||
== 3D Structures of Leukotriene B4 hydroxydehydrogenase == | == 3D Structures of Leukotriene B4 hydroxydehydrogenase == | ||
| Line 9: | Line 17: | ||
[[1v3t]], [[1v3u]] - gpLB4H/15-oxo-prostaglandin 13-reductase<br /> | [[1v3t]], [[1v3u]] - gpLB4H/15-oxo-prostaglandin 13-reductase<br /> | ||
[[1v3v]] - gpLB4H/15-oxo-prostaglandin 13-reductase+NADP+15-oxo-PGE-2<br /> | [[1v3v]] - gpLB4H/15-oxo-prostaglandin 13-reductase+NADP+15-oxo-PGE-2<br /> | ||
| - | + | == References == | |
| + | <references/> | ||
[[Category:Topic Page]] | [[Category:Topic Page]] | ||
Revision as of 08:04, 13 April 2016
| |||||||||||
Structural highlights
3D Structures of Leukotriene B4 hydroxydehydrogenase
1zsv – LB4H - human
2dm6 –gpLB4H/15-oxo-prostaglandin 13-reductase+indomethacin – guinea pig
1v3t, 1v3u - gpLB4H/15-oxo-prostaglandin 13-reductase
1v3v - gpLB4H/15-oxo-prostaglandin 13-reductase+NADP+15-oxo-PGE-2
References
- ↑ Tobin DM, Roca FJ, Ray JP, Ko DC, Ramakrishnan L. An enzyme that inactivates the inflammatory mediator leukotriene b4 restricts mycobacterial infection. PLoS One. 2013 Jul 11;8(7):e67828. doi: 10.1371/journal.pone.0067828. Print 2013. PMID:23874453 doi:http://dx.doi.org/10.1371/journal.pone.0067828
- ↑ Hori T, Yokomizo T, Ago H, Sugahara M, Ueno G, Yamamoto M, Kumasaka T, Shimizu T, Miyano M. Structural basis of leukotriene B4 12-hydroxydehydrogenase/15-Oxo-prostaglandin 13-reductase catalytic mechanism and a possible Src homology 3 domain binding loop. J Biol Chem. 2004 May 21;279(21):22615-23. Epub 2004 Mar 8. PMID:15007077 doi:10.1074/jbc.M312655200

